Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
63 studies found for:    cannabidiol
Show Display Options
Rank Status Study
1 Recruiting Cannabidiol as a Different Type of an Antipsychotic: Drug Delivery and Interaction Study
Condition: Schizophrenia
Interventions: Drug: Cannabidiol CR;   Drug: Cannabidiol;   Drug: Amisulpride;   Drug: Olanzapine;   Drug: Quetiapine;   Drug: Risperidone;   Drug: Placebo
2 Completed Cannabidiol for Inflammatory Bowel Disease
Conditions: Crohn's Disease;   Ulcerative Colitis
Interventions: Drug: cannabidiol;   Drug: placebo in drops
3 Recruiting Cannabidiol for Graft Versus Host Disease (GVHD) Prophylaxis in Allogeneic Stem Cell Transplantation
Condition: Graft Versus Host Disease
Intervention: Drug: Oral Cannabidiol
4 Recruiting Safety and Efficacy of Cannabidiol for Grade I/II Acute Graft Versus Host Disease (GVHD) After Allogeneic Stem Cell Transplantation
Condition: Graft Versus Host Disease
Intervention: Drug: Cannabidiol
5 Completed Study to Test the Safety and Efficacy of Cannabidiol as a Treatment Intervention for Opioid Relapse
Condition: Opiate Addiction
Interventions: Drug: Cannabidiol;   Drug: Fentanyl
6 Recruiting A Four-week Clinical Trial Investigating Efficacy and Safety of Cannabidiol as a Treatment for Acutely Ill Schizophrenic Patients
Condition: Schizophrenia
Interventions: Drug: Cannabidiol;   Drug: Olanzapine;   Drug: Placebo Cannabidiol;   Drug: Placebo Olanzapine
7 Not yet recruiting Laboratory Study of Cannabidiol on the Effects of Smoked Marijuana
Condition: Smoking, Marijuana
Intervention: Drug: cannabidiol
8 Completed
Has Results
Study to Assess the Effect of Cannabidiol on Liver Fat Levels in Subjects With Fatty Liver Disease.
Condition: Fatty Liver
Intervention: Drug: Cannabidiol
9 Active, not recruiting Acute and Short-term Effects of Cannabidiol Administration on Cue-induced Craving in Drug-abstinent Heroin Dependent Subjects
Condition: Opiate Addiction
Interventions: Drug: Cannabidiol;   Drug: Placebo
10 Recruiting The Effects of Cannabidiol and ∆-9-THC in Humans
Condition: Healthy
Interventions: Drug: Cannabidiol;   Drug: Delta-9-THC;   Drug: Placebo
11 Recruiting Cannabidiol: a Novel Intervention for Cannabis Use Problems?
Condition: Cannabis Use Disorder
Interventions: Drug: Cannabidiol;   Drug: Placebo
12 Completed A Clinical Trial on the Antipsychotic Properties of Cannabidiol
Conditions: Schizophrenia;   Psychotic Disorders
Interventions: Drug: Placebo/Cannabidiol;   Drug: Cannabidiol/Placebo
13 Active, not recruiting Cannabidiol (CBD) for the Management of Cannabis Withdrawal: A Phase II Proof of Concept Study
Condition: Cannabis Use Disorder
Intervention: Drug: CBD
14 Not yet recruiting A Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P) in Children and Young Adults With Dravet Syndrome
Conditions: Epilepsy;   Dravet Syndrome
Interventions: Drug: GWP42003-P;   Drug: Placebo Control
15 Not yet recruiting An Open Label Extension Study of Cannabidiol (GWP42003-P) in Children and Young Adults With Dravet or Lennox-Gastaut Syndromes
Conditions: Epilepsy;   Dravet Syndrome;   Lennox-Gastaut Syndrome
Intervention: Drug: GWP42003-P
16 Recruiting Cannabidiol (CBD) to 25 Patients (Aged 2 Years - 19 Years) With Drug Resistant Epilepsy
Condition: Epilepsy
Intervention: Drug: Cannabidiol
17 Not yet recruiting A Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P; CBD) as Adjunctive Treatment for Seizures Associated With Lennox-Gastaut Syndrome in Children and Adults
Conditions: Epilepsy;   Lennox-Gastaut Syndrome
Interventions: Drug: GWP42003-P;   Drug: Placebo control
18 Not yet recruiting A Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P; CBD) as Adjunctive Treatment for Seizures Associated With Lennox-Gastaut Syndrome in Children and Adults
Conditions: Epilepsy;   Lennox-Gastaut Syndrome
Interventions: Drug: GWP42003-P;   Drug: Placebo Control
19 Recruiting Processing of Salient Emotional Stimuli as a Function of Tetrahydrocannabinol (THC) and Cannabidiol (CBD)
Condition: Healthy Humans
Interventions: Drug: tetrahydrocannabinol;   Drug: cannabidiol;   Other: placebo
20 Completed Cannabidiol Treatment of Cognitive Dysfunction in Schizophrenia
Conditions: Schizophrenia;   Schizoaffective Disorder
Interventions: Drug: Cannabidiol;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years